Human Stem Cell Therapy for the Cure of Type 1 Diabetes Mellitus (T1D): A Hurdle Course between Lights and Shadows
<b>Background:</b> T1D is a severe metabolic disorder due to selective autoimmune pancreatic islet β-cell killing, which results in complete abrogation of endogenous insulin secretion. The affected patients, once the disease is clinically overt, must immediately undertake insulin supplem...
Saved in:
| Main Authors: | Riccardo Calafiore, Giovanni Luca, Francesco Gaggia, Giuseppe Basta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Endocrines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-396X/5/4/34 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective role of self-assembled nanoparticle vaccine of Pseudomonas aeruginosa in a mouse model of bronchiectasis with acute infection
by: WU Ziyu, et al.
Published: (2025-05-01) -
Research on inner membrane complex protein 1: a novel nanovaccines against Toxoplasma gondii
by: YunNan Fang, et al.
Published: (2025-08-01) -
Secreted protein NFA47630 from Nocardia farcinica IFM10152 induces immunoprotective effects in mice
by: Lichao Han, et al.
Published: (2024-10-01) -
Prescribing insulin in type 1 diabetes mellitus: an update for general practitioners
by: J.A. Dave, et al.
Published: (2007-12-01) -
Evaluation of acellular pertussis vaccine: comparisons among different strains of mice
by: Jie Wei, et al.
Published: (2023-12-01)